Gene · 5893
Papers2,797
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,797
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. | Cells | 2023 | 37508568 | PubTator, text mining | PubMed |
| Distinct characteristics of two types of alternative lengthening of telomeres in mouse embryonic stem cells. | Nucleic Acids Res | 2023 | 37496110 | PubTator, text mining | PubMed |
| Bioorthogonal CRISPR/Cas9-Drug Conjugate: A Combinatorial Nanomedicine Platform. | Adv Sci (Weinh) | 2023 | 37485817 | PubTator, text mining | PubMed |
| Efficient high-precision homology-directed repair-dependent genome editing by HDRobust. | Nat Methods | 2023 | 37474806 | PubTator, text mining | PubMed |
| Different SWI/SNF complexes coordinately promote R-loop- and RAD52-dependent transcription-coupled homologous recombination. | Nucleic Acids Res | 2023 | 37470997 | PubTator, text mining | PubMed |
| Live cell single-molecule imaging to study DNA repair in human cells. | DNA Repair (Amst) | 2023 | 37467632 | PubTator, text mining | PubMed |
| Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3. | Nat Commun | 2023 | 37463936 | PubTator, text mining | PubMed |
| Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC. | Nat Commun | 2023 | 37454214 | PubTator, text mining | PubMed |
| Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade. | Int J Mol Sci | 2023 | 37446144 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency (HRD) in Cutaneous Oncology. | Int J Mol Sci | 2023 | 37445949 | PubTator, text mining | PubMed |
| Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer. | Int J Mol Sci | 2023 | 37445737 | PubTator, text mining | PubMed |
| The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork. | Int J Mol Sci | 2023 | 37445667 | PubTator, text mining | PubMed |
| RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy. | Cell Biosci | 2023 | 37420298 | PubTator, text mining | PubMed |
| The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment. | Front Oncol | 2023 | 37409248 | PubTator, text mining | PubMed |
| FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancer. | Res Sq | 2023 | 37398210 | PubTator, text mining | PubMed |
| Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing. | Technol Cancer Res Treat | 2023 | 37394872 | PubTator, text mining | PubMed |
| ssDNA accessibility of Rad51 is regulated by orchestrating multiple RPA dynamics. | Nat Commun | 2023 | 37391417 | PubTator, text mining | PubMed |
| Alteration of replication protein A binding mode on single-stranded DNA by NSMF potentiates RPA phosphorylation by ATR kinase. | Nucleic Acids Res | 2023 | 37378431 | PubTator, text mining | PubMed |
| Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice. | Cancers (Basel) | 2023 | 37370804 | PubTator, text mining | PubMed |
| Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells. | Mol Cancer Res | 2023 | 37358557 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5893/papers?page=11